The growing demand for controlled immunological investigation and therapeutic creation has spurred significant advances in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression platforms, including prokaryotic hosts, animal cell cultures, an